Neuroone Medical Technologies Stock Analysis

Neuroone Stock Analysis Notes

About 16.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.46. Neuroone Medical Tec had not issued any dividends in recent years. The entity had 1:3 split on the 1st of April 2021. NeuroOne Medical Technologies Corporation operates as a medical technology company. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOnes combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. Neuroone Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 11 people. To find out more about Neuroone Medical Technologies contact David MD at 952 426 1383 or learn more at https://www.n1mtc.com.

Neuroone Medical Tec Investment Alerts

Neuroone Medical Tec Upcoming and Recent Events

Neuroone Largest EPS Surprises

View All Earnings Estimates

Neuroone Stock Institutional Investors

Note, although Neuroone Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Neuroone Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.38 M.

Neuroone Profitablity

Management Efficiency

Neuroone Medical Tec has return on total asset (ROA) of (1.4333) % which means that it has lost $1.4333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.4913) %, meaning that it created substantial loss on money invested by shareholders. Neuroone Medical's management efficiency ratios could be used to measure how well Neuroone Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Neuroone Medical's Return On Equity is projected to drop based on the last few years of reporting. At present, Neuroone Medical's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 377 K, whereas Total Assets are forecasted to decline to about 3 M.

Technical Drivers

As of the 22nd of December, Neuroone Medical secures the Risk Adjusted Performance of (0.02), mean deviation of 4.06, and Standard Deviation of 5.63. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neuroone Medical Tec, as well as the relationship between them.

Neuroone Medical Tec Price Movement Analysis

Neuroone Medical Tec Insider Trading Activities

Neuroone Medical Outstanding Bonds

Neuroone Medical Predictive Daily Indicators

Neuroone Medical Forecast Models

Neuroone Medical's time-series forecasting models are one of many Neuroone Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Neuroone Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Neuroone Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Neuroone shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Neuroone Medical. By using and applying Neuroone Stock analysis, traders can create a robust methodology for identifying Neuroone entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Neuroone analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Neuroone analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Neuroone Medical Technologies stock analysis indicators help investors evaluate how Neuroone Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Neuroone Medical shares will generate the highest return on investment. By understating and applying Neuroone Medical stock analysis, traders can identify Neuroone Medical position entry and exit signals to maximize returns.

When running Neuroone Medical's price analysis, check to measure Neuroone Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuroone Medical is operating at the current time. Most of Neuroone Medical's value examination focuses on studying past and present price action to predict the probability of Neuroone Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuroone Medical's price. Additionally, you may evaluate how the addition of Neuroone Medical to your portfolios can decrease your overall portfolio volatility.